Peanut Allergy Rates in Toddlers Drop 43% Over Ten Years

Recent data indicates a major shift in pediatric health outcomes. Peanut allergy rates in children under the age of three have declined by roughly 43 percent over the last decade. This drop follows a change in medical guidance regarding when parents should introduce specific foods to their infants. The trend reflects a move away from long-standing advice that recommended avoiding peanut products for young children.

Researchers suggest the previous approach may have been counterproductive. New studies indicate that introducing peanut products to infants between four and six months of age can reduce the risk of developing a peanut allergy. The findings support an earlier timeline for exposure. This shift in clinical understanding aligns with the observed decrease in diagnoses among toddlers.

The Aging Untold program, which aired on October 30, 2026, featured this research alongside other health topics for older adults. The broadcast addressed how age and illness impact intimacy and offered practical advice for couples. It also covered the role of older adults in clinical trials and the benefits of physical activity at advanced ages.

Gerontologist Sam Cradduck spoke on the episode about intimacy and aging. She stated that the first step for couples is to determine what is behind any changes in their sexual activity. Cradduck emphasized that competence and consent are the primary considerations. For physical issues such as erectile dysfunction, she noted that medical professionals can often provide solutions.

Dr. Rhea Rogers, a board-certified physician, discussed the difference between intimacy and sexuality. Rogers said a common misconception is treating the two concepts as interchangeable. She advised that they are distinct aspects of a relationship. This distinction is important for couples navigating health changes.

Rogers also addressed the participation of older adults in clinical trials. She noted that this demographic is frequently underrepresented in studies. However, she described trials as a proactive way to explore new treatments. Rogers warned against viewing trials only as a last resort. She highlighted that participants gain access to future medicines, devices, and therapies that may not be available to the general public for years.

Aging expert Amy O'Rourke added a caution for potential trial participants. She advised that individuals should understand they might receive a placebo. This transparency is a standard part of the trial process. The program included a feature on Flo Meiler, a 91-year-old track and field competitor from Vermont. Meiler began competing at age 60 and currently holds two world records.

Meiler stated that she enjoys competing despite physical changes. She said, 'I’m sad that I can’t jump like I used to, but I really enjoy it.' Her continued participation illustrates that staying active does not have a strict age limit. The episode provided information on how to find clinical trials and which ones offer compensation to participants. The program included a disclaimer that it is for educational purposes and not a substitute for professional medical advice.